ArticleJournal of the Endocrine Society2021

Synergism of Checkpoint Inhibitors and Peptide Receptor Radionuclide Therapy in the Treatment of Pituitary Carcinoma.

Andrew L Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.